These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22455462)

  • 21. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
    Wu WN; McKown LA; Reitz AB
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of time-dependent artesunate pharmacokinetics in healthy subjects during 5-day oral administration.
    Diem Thuy LT; Ngoc Hung L; Danh PT; Na-Bangchang K
    Eur J Clin Pharmacol; 2008 Oct; 64(10):993-8. PubMed ID: 18600318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2'- (methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)- 1H-pyrazole-5-carboxamide (DPC 423) by novel metabolic pathways. Characterization of unusual metabolites by liquid chromatography/mass spectrometry and NMR.
    Mutlib AE; Shockcor J; Chen SY; Espina RJ; Pinto DJ; Orwat MJ; Prakash SR; Gan LS
    Chem Res Toxicol; 2002 Jan; 15(1):48-62. PubMed ID: 11800597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of domperidone metabolites in plasma and urine of gastroparesis patients with LC-ESI-MS/MS.
    Youssef AS; Argikar UA; Pathikonda M; Parkman HP; Nagar S
    Xenobiotica; 2013 Dec; 43(12):1073-83. PubMed ID: 23705785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A practical strategy for characterization of the metabolic profile of chiral drugs using combinatory liquid chromatography-mass spectrometric techniques: application to tetrahydropalmatine enantiomers and their metabolites in rat urine.
    Zhang Y; Dong X; Le J; Wen J; Lin Z; Liu Y; Lou Z; Chai Y; Hong Z
    J Pharm Biomed Anal; 2014 Jun; 94():152-62. PubMed ID: 24598170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liquid chromatography-tandem mass spectrometry assay for the quantitation of beta-dihydroartemisinin in rat plasma.
    Xing J; Yan HX; Wang RL; Zhang LF; Zhang SQ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):202-7. PubMed ID: 17267300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous determination of artesunic acid and dihydroartemisinin in blood plasma by high-performance liquid chromatography for application in clinical pharmacological studies.
    Navaratnam V; Mordi MN; Mansor SM
    J Chromatogr B Biomed Sci Appl; 1997 Apr; 692(1):157-62. PubMed ID: 9187395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats.
    Li QG; Peggins JO; Fleckenstein LL; Masonic K; Heiffer MH; Brewer TG
    J Pharm Pharmacol; 1998 Feb; 50(2):173-82. PubMed ID: 9530985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of artemether and dihydroartemisinin in blood plasma by high-performance liquid chromatography for application in clinical pharmacological studies.
    Navaratnam V; Mansor SM; Chin LK; Mordi MN; Asokan M; Nair NK
    J Chromatogr B Biomed Appl; 1995 Jul; 669(2):289-94. PubMed ID: 7581905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of in vivo and in vitro metabolites of 4,5-dimethoxycanthin-6-one by HPLC-Q-TOF-MS/MS.
    Miao X; Wang J; Chen L; Peng Z; Chen Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1020():78-84. PubMed ID: 27030894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liquid chromatographic tandem mass spectrometric assay for quantification of 97/78 and its metabolite 97/63: a promising trioxane antimalarial in monkey plasma.
    Singh RP; Sabarinath S; Gautam N; Gupta RC; Singh SK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):2074-80. PubMed ID: 19520624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A high-performance liquid chromatography/tandem mass spectrometry method for the determination of artemisinin in rat plasma.
    Xing J; Yan H; Zhang S; Ren G; Gao Y
    Rapid Commun Mass Spectrom; 2006; 20(9):1463-8. PubMed ID: 16586460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and characterization of urinary metabolites of boldione by LC-MS/MS. Part I: Phase I metabolites excreted free, as glucuronide and sulfate conjugates, and released after alkaline treatment of the urine.
    Gómez C; Pozo OJ; Fabregat A; Marcos J; Deventer K; Van Eenoo P; Segura J; Ventura R
    Drug Test Anal; 2012 Oct; 4(10):775-85. PubMed ID: 23090723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of antimalarial compound, ARB-89 (7β-hydroxy-artemisinin carbamate) in rat serum by UPLC/MS/MS and its application in pharmacokinetics.
    Pabbisetty D; Illendula A; Muraleedharan KM; Chittiboyina AG; Williamson JS; Avery MA; Avery BA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 889-890():123-9. PubMed ID: 22365535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic profile of 1,5-dicaffeoylquinic acid in rats, an in vivo and in vitro study.
    Yang B; Meng Z; Dong J; Yan L; Zou L; Tang Z; Dou G
    Drug Metab Dispos; 2005 Jul; 33(7):930-6. PubMed ID: 15802385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LC-HRMS methods for the quantification of two artemisinin drugs and their metabolites in rat blood and plasma.
    Zhou H; Mao H; Xing J
    Biomed Chromatogr; 2024 May; 38(5):e5844. PubMed ID: 38326977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic study of harmane and its 10 metabolites in rat after intravenous and oral administration by UPLC-ESI-MS/MS.
    Li S; Teng L; Liu W; Cheng X; Jiang B; Wang Z; Wang CH
    Pharm Biol; 2016 Sep; 54(9):1768-81. PubMed ID: 26730489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of high performance liquid chromatography-electrochemical detection methods with simultaneous extraction procedure for the determination of artesunate, dihydroartemisinin, amodiaquine and desethylamodiaquine in human plasma for application in clinical pharmacological studies of artesunate-amodiaquine drug combination.
    Lai CS; Nair NK; Muniandy A; Mansor SM; Olliaro PL; Navaratnam V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(5-6):558-62. PubMed ID: 19147417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the metabolites of H3B-6545 in vitro and in vivo by using ultra-high performance liquid chromatography combined with electrospray ionization linear ion trap-orbitrap tandem mass spectrometry.
    Zhang D; Hao X; Xu L; Yang Y; Zhao H
    Biomed Chromatogr; 2020 Feb; 34(2):e4746. PubMed ID: 31725913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of metabolites of novel Anti-MRSA fluoroquinolone WCK 771 in mouse, rat, rabbit, dog, monkey and human urine using liquid chromatography tandem mass spectrometry.
    Yeole RD; Rane VP; Ahirrao VK; Chavan RP; Patel AM; Deshpande PK; Patel MV; Patil KR
    Biomed Chromatogr; 2019 Jul; 33(7):e4532. PubMed ID: 30861568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.